Affluent Medical SAS (AFME) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.319x

Based on the latest financial reports, Affluent Medical SAS (AFME) has a cash flow conversion efficiency ratio of -0.319x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-6.74 Million ≈ $-7.88 Million USD) by net assets (€21.11 Million ≈ $24.68 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Affluent Medical SAS (AFME) net asset quality to measure how much of total assets are equity-financed.

Affluent Medical SAS - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Affluent Medical SAS's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore debt repayment capacity of Affluent Medical SAS to assess how comfortably operating cash covers total debt obligations.

Affluent Medical SAS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Affluent Medical SAS ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
FCR Immobilien AG XETRA:FC9	0.076x
New Era Electronics Co Ltd TWO:4909	-0.007x
BICO Group AB ST:BICO	-0.017x
Triple i Logistics Public Company Limited BK:III	0.022x
Patria Bank SA RO:PBK	0.240x
Captor Therapeutics S.A. WAR:CTX	-0.346x
Clarus Corp NASDAQ:CLAR	-0.021x
DAEYANG ELECTRIC.Co.Ltd KQ:108380	-0.004x

Annual Cash Flow Conversion Efficiency for Affluent Medical SAS (2016–2024)

The table below shows the annual cash flow conversion efficiency of Affluent Medical SAS from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Affluent Medical SAS.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€30.27 Million ≈ $35.39 Million	€-11.32 Million ≈ $-13.24 Million	-0.374x	+2.33%
2023-12-31	€31.47 Million ≈ $36.79 Million	€-12.05 Million ≈ $-14.09 Million	-0.383x	-16.94%
2022-12-31	€33.83 Million ≈ $39.55 Million	€-11.08 Million ≈ $-12.95 Million	-0.328x	-15.33%
2021-12-31	€43.53 Million ≈ $50.90 Million	€-12.36 Million ≈ $-14.45 Million	-0.284x	-12.16%
2020-12-31	€35.29 Million ≈ $41.26 Million	€-8.94 Million ≈ $-10.45 Million	-0.253x	+35.66%
2019-12-31	€30.96 Million ≈ $36.20 Million	€-12.19 Million ≈ $-14.25 Million	-0.394x	-122.87%
2017-12-31	€61.39 Million ≈ $71.78 Million	€-10.84 Million ≈ $-12.68 Million	-0.177x	+4.12%
2016-12-31	€58.87 Million ≈ $68.82 Million	€-10.84 Million ≈ $-12.68 Million	-0.184x	--

About Affluent Medical SAS

PA:AFME France Medical Devices

Market Cap

$129.10 Million

€110.43 Million EUR

Market Cap Rank

#18811 Global

#279 in France

Share Price

€2.81

Change (1 day)

+0.36%

52-Week Range

€1.33 - €2.81

All Time High

€8.30